Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $2.11 million. The enterprise value is $14.97 million.
| Market Cap | 2.11M |
| Enterprise Value | 14.97M |
Important Dates
The next estimated earnings date is Monday, November 16, 2026, before market open.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 520,140 shares outstanding.
| Current Share Class | 520,140 |
| Shares Outstanding | 520,140 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +56.87% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 0.77% |
| Float | 343,895 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| Forward PS | 0.23 |
| PB Ratio | 0.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 2.53.
| Current Ratio | 0.74 |
| Quick Ratio | 0.17 |
| Debt / Equity | 2.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.15 |
Financial Efficiency
Return on equity (ROE) is -548.83% and return on invested capital (ROIC) is -51.73%.
| Return on Equity (ROE) | -548.83% |
| Return on Assets (ROA) | -38.04% |
| Return on Invested Capital (ROIC) | -51.73% |
| Return on Capital Employed (ROCE) | -239.75% |
| Weighted Average Cost of Capital (WACC) | 4.60% |
| Revenue Per Employee | $591,809 |
| Profits Per Employee | -$1.12M |
| Employee Count | 47 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 0.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.67% in the last 52 weeks. The beta is -0.11, so Jaguar Health's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -99.67% |
| 50-Day Moving Average | 10.93 |
| 200-Day Moving Average | 177.57 |
| Relative Strength Index (RSI) | 44.36 |
| Average Volume (20 Days) | 3,806,538 |
Short Selling Information
The latest short interest is 326,132, so 62.70% of the outstanding shares have been sold short.
| Short Interest | 326,132 |
| Short Previous Month | 242,001 |
| Short % of Shares Out | 62.70% |
| Short % of Float | 94.83% |
| Short Ratio (days to cover) | 0.68 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $27.82 million and -$52.42 million in losses. Loss per share was -$2,338.09.
| Revenue | 27.82M |
| Gross Profit | 22.89M |
| Operating Income | -25.10M |
| Pretax Income | -36.92M |
| Net Income | -52.42M |
| EBITDA | -23.19M |
| EBIT | -25.10M |
| Loss Per Share | -$2,338.09 |
Balance Sheet
The company has $3.79 million in cash and $16.65 million in debt, with a net cash position of -$12.86 million or -$24.73 per share.
| Cash & Cash Equivalents | 3.79M |
| Total Debt | 16.65M |
| Net Cash | -12.86M |
| Net Cash Per Share | -$24.73 |
| Equity (Book Value) | 6.57M |
| Book Value Per Share | 20.43 |
| Working Capital | -6.19M |
Cash Flow
In the last 12 months, operating cash flow was -$6.69 million and capital expenditures -$41,000, giving a free cash flow of -$6.73 million.
| Operating Cash Flow | -6.69M |
| Capital Expenditures | -41,000 |
| Depreciation & Amortization | 1.90M |
| Net Borrowing | 2.90M |
| Free Cash Flow | -6.73M |
| FCF Per Share | -$12.93 |
Margins
Gross margin is 82.31%, with operating and profit margins of -90.22% and -130.85%.
| Gross Margin | 82.31% |
| Operating Margin | -90.22% |
| Pretax Margin | -132.73% |
| Profit Margin | -130.85% |
| EBITDA Margin | -83.38% |
| EBIT Margin | -90.22% |
| FCF Margin | n/a |
Dividends & Yields
Jaguar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2,239.57% |
| FCF Yield | -287.36% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 221.30% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 17, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 17, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Jaguar Health has an Altman Z-Score of -18.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.26 |
| Piotroski F-Score | 4 |